Mosaic down syndrome in a patient with low-level mosaicism detected by microarray

Eyby Leon, Ying Zou, Jeff M. Milunsky

Research output: Contribution to journalArticle

Abstract

Down syndrome (DS) is the most common aneuploidy in liveborns with an estimated frequency of 1 in 650-1,000 births. Approximately 1-2% of all live-born DS individuals have mosaicism. The correlation between the percentage of mosaicism and the severity of the phenotype in mosaic trisomy 21 has been determined in previous studies. Patients with low percent of trisomy 21 have less phenotypic manifestations, higher IQs, and better overall survival. We report on a 1-day-old baby girl with subtle features of DS and low-level trisomy 21 mosaicism (8-13% in lymphocytes, 31% in buccal cells) with normal high resolution chromosome analysis. The aneuploidy was detected by 6.0 SNP microarray and confirmed by fluorescent in situ hybridization (FISH). Further studies to detect mosaicism are recommended from blood (using interphase FISH) or other tissues in the evaluation of a child with features of DS and a normal blood metaphase karyotype. SNP microarray technology appears to be a useful adjunct, being able to detect low-level mosaicism in these cases.

Original languageEnglish (US)
Pages (from-to)3154-3156
Number of pages3
JournalAmerican Journal of Medical Genetics, Part A
Volume152 A
Issue number12
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Mosaicism
Down Syndrome
Aneuploidy
Fluorescence In Situ Hybridization
Single Nucleotide Polymorphism
Cheek
Interphase
Metaphase
Karyotype
Chromosomes
Parturition
Lymphocytes
Technology
Phenotype
Survival

Keywords

  • Down syndrome
  • Microarray
  • Mosaicism
  • SNP
  • Trisomy 21

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Mosaic down syndrome in a patient with low-level mosaicism detected by microarray. / Leon, Eyby; Zou, Ying; Milunsky, Jeff M.

In: American Journal of Medical Genetics, Part A, Vol. 152 A, No. 12, 01.12.2010, p. 3154-3156.

Research output: Contribution to journalArticle

@article{ec9918f614d246c98dfd20d459a3efef,
title = "Mosaic down syndrome in a patient with low-level mosaicism detected by microarray",
abstract = "Down syndrome (DS) is the most common aneuploidy in liveborns with an estimated frequency of 1 in 650-1,000 births. Approximately 1-2{\%} of all live-born DS individuals have mosaicism. The correlation between the percentage of mosaicism and the severity of the phenotype in mosaic trisomy 21 has been determined in previous studies. Patients with low percent of trisomy 21 have less phenotypic manifestations, higher IQs, and better overall survival. We report on a 1-day-old baby girl with subtle features of DS and low-level trisomy 21 mosaicism (8-13{\%} in lymphocytes, 31{\%} in buccal cells) with normal high resolution chromosome analysis. The aneuploidy was detected by 6.0 SNP microarray and confirmed by fluorescent in situ hybridization (FISH). Further studies to detect mosaicism are recommended from blood (using interphase FISH) or other tissues in the evaluation of a child with features of DS and a normal blood metaphase karyotype. SNP microarray technology appears to be a useful adjunct, being able to detect low-level mosaicism in these cases.",
keywords = "Down syndrome, Microarray, Mosaicism, SNP, Trisomy 21",
author = "Eyby Leon and Ying Zou and Milunsky, {Jeff M.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1002/ajmg.a.33739",
language = "English (US)",
volume = "152 A",
pages = "3154--3156",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Mosaic down syndrome in a patient with low-level mosaicism detected by microarray

AU - Leon, Eyby

AU - Zou, Ying

AU - Milunsky, Jeff M.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Down syndrome (DS) is the most common aneuploidy in liveborns with an estimated frequency of 1 in 650-1,000 births. Approximately 1-2% of all live-born DS individuals have mosaicism. The correlation between the percentage of mosaicism and the severity of the phenotype in mosaic trisomy 21 has been determined in previous studies. Patients with low percent of trisomy 21 have less phenotypic manifestations, higher IQs, and better overall survival. We report on a 1-day-old baby girl with subtle features of DS and low-level trisomy 21 mosaicism (8-13% in lymphocytes, 31% in buccal cells) with normal high resolution chromosome analysis. The aneuploidy was detected by 6.0 SNP microarray and confirmed by fluorescent in situ hybridization (FISH). Further studies to detect mosaicism are recommended from blood (using interphase FISH) or other tissues in the evaluation of a child with features of DS and a normal blood metaphase karyotype. SNP microarray technology appears to be a useful adjunct, being able to detect low-level mosaicism in these cases.

AB - Down syndrome (DS) is the most common aneuploidy in liveborns with an estimated frequency of 1 in 650-1,000 births. Approximately 1-2% of all live-born DS individuals have mosaicism. The correlation between the percentage of mosaicism and the severity of the phenotype in mosaic trisomy 21 has been determined in previous studies. Patients with low percent of trisomy 21 have less phenotypic manifestations, higher IQs, and better overall survival. We report on a 1-day-old baby girl with subtle features of DS and low-level trisomy 21 mosaicism (8-13% in lymphocytes, 31% in buccal cells) with normal high resolution chromosome analysis. The aneuploidy was detected by 6.0 SNP microarray and confirmed by fluorescent in situ hybridization (FISH). Further studies to detect mosaicism are recommended from blood (using interphase FISH) or other tissues in the evaluation of a child with features of DS and a normal blood metaphase karyotype. SNP microarray technology appears to be a useful adjunct, being able to detect low-level mosaicism in these cases.

KW - Down syndrome

KW - Microarray

KW - Mosaicism

KW - SNP

KW - Trisomy 21

UR - http://www.scopus.com/inward/record.url?scp=78649685698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649685698&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33739

DO - 10.1002/ajmg.a.33739

M3 - Article

C2 - 21108401

AN - SCOPUS:78649685698

VL - 152 A

SP - 3154

EP - 3156

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 12

ER -